{"symbol":"ABT","fiscalQuarter":"Q1-2018","reportDate":"2018-04-18","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q1-2018","postBrief":{"headline":"Abbott Labs Misses on EPS, Stock Down 0.47%","keyNumbers":[{"metric":"EPS","actual":"$0.59","expected":"N/A","surprise":"-0.42%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management noted challenges in the current market environment.","They emphasized a focus on long-term growth despite short-term pressures."],"summary":"Overall, management expressed caution regarding market conditions. They highlighted ongoing investments in innovation as a priority."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported an EPS of $0.59, slightly missing expectations, which contributed to a 0.47% decline in stock price. The lack of revenue details and forward guidance may have added to investor concerns. Management's cautious tone suggests they are navigating a challenging market but remain focused on long-term strategies.","metaDescription":"Abbott Labs (ABT) Q1 2018 earnings: EPS missed expectations. Stock down 0.47%. Full breakdown."}}